Cargando…
小细胞肺癌目前治疗的策略与未来方向
Small cell lung cancer (SCLC) is a malignant tumor with a very high mortality rate. The current standard of care includes surgery, chemotherapy and radiotherapy. The clinical benefit of therapies was disappointing. Recently, many clinical trials about target therapy and immunotherapy are processing....
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973356/ https://www.ncbi.nlm.nih.gov/pubmed/28641701 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.06.09 |